News

Bacterial invasion may explain recurrent urinary tract infections

Courtney Chandler
November 01, 2019

Urinary tract infections, better known as UTIs, are the most common bacterial infection in women of all ages, and an estimated 50% of women will experience a UTI at least once during their lives.

Postmenopausal women are especially susceptible and many suffer from repeated infections. Recent research suggests that this recurrence may partially be explained by where the infecting bacteria go — namely, into the walls of the bladder.

Bacteria

Kim Orth, a professor at the University of Texas Southwestern Medical Center, and Nicole DeNisco, an assistant professor at the University of Texas, Dallas, along with colleagues at UT Southwestern found bacteria in bladder-wall biopsy samples of postmenopausal women. The presence of these bacteria within the tissue seemed to initiate local adaptive immune responses, which may contribute to the pathology of recurrent UTIs, or RUTIs.

Orth and DeNisco partnered with urologist Philippe Zimmern to study the host-pathogen interactions involved in RUTI using urine from postmenopausal women as well as the bladder-wall samples. They expected to find bacterial species associated with bladder and urinary tract infections, such as Escherichia coli. Instead, they saw that more diverse species of bacteria were able to invade the bladder’s surface, which is called the urothelium.

“These results were very surprising as we expected to see E. coli associated with all of the patients,” Orth said. “Instead, we found a number of different types of bacteria that correlated with diseased tissue.”

When they examined and analyzed the tissue further, the research team found both swelling and an increased presence of antibody-secreting B-cell lymphocytes, a key component of the adaptive immune response; normally, in the absence of infection, antibody-secreting B-cell lymphocytes are at low levels. Scientists long have thought that this response may contribute to RUTI; these findings support that theory and provide better insight into the disease mechanism.

Women with RUTIs spend billions of dollars annually on medical care, and the pain and discomfort associated with the infection can lead to reduced quality of life. Anti- biotics are the standard prescribed treatment, but doctors are seeing a rise in antibiotic-resistant RUTIs, which are especially difficult to treat. Yet research on the underlying cause can be challenging. Most studies are done on mice, which have limited lifespans and don’t accurately represent postmenopausal women. Orth, DeNisco and Zimmern’s study of postmenopausal patient samples is, therefore, important.

“Solid data about what causes the disease from patients that have RUTI, rather than making assumptions, is in itself a major breakthrough,” Orth said.

Future research can build on Orth, DeNisco and Zimmern’s findings to learn how different treatments affect RUTIs both for patient outcome and at the molecular level at the site of infection itself. They have planned future studies on how to remove the invading bacteria from the bladder and target the local immune response effectively. The results could help guide medical treatment plans to reduce the recurrence of UTIs in postmenopausal women.

Courtney Chandler

Courtney Chandler is a postdoctoral researcher at Johns Hopkins University and an industry careers columnist for ASBMB Today.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A small army of researchers races to build a coronavirus interactome
News

A small army of researchers races to build a coronavirus interactome

April 01, 2020

Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.

Parkinson's  Awareness Month
Health Observance

Parkinson's Awareness Month

April 01, 2020

It is the second-most common progressive neurodegenerative disease, occurring in 1% of people over the age of 60 and in 5% of people over 85.

Multiomics meets antimalarials
Journal News

Multiomics meets antimalarials

March 31, 2020

Researchers in Australia use an innovative multiomics approach to analyze a new drug against malaria parasites.

From the journals: JLR
Journal News

From the journals: JLR

March 31, 2020

Topics include the role of HDL and Smo in inhibiting beta-cell apoptosis, lipid asymmetry in a plasma membrane and apolipoproteins and dementia risk.

Researchers retool genomics labs to provide COVID-19 testing
News

Researchers retool genomics labs to provide COVID-19 testing

March 30, 2020

The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.

Research on a budget
Essay

Research on a budget

March 30, 2020

As a professor at a small university, Peter Lyons has developed ways of reaching his research goals with limited funding, and he shares some of them here.